NCT01468129
Unknown
N/A
A Prospective, Randomized Controlled Trial to Evaluate the Efficacy of Cell Saver to Redue Blood Loss in One-stage Bilateral Total Hip Arthroplasty (THA)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- One-stage Bilateral Total Hip Replacement
- Sponsor
- Rothman Institute Orthopaedics
- Locations
- 1
- Last Updated
- 14 years ago
Overview
Brief Summary
This study will investigate the efficacy of using cell saver during bilater total hip arthroplasty
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subject is over 21 years of age
- •Subject with bilateral degenerative disease of hips who are candidate for one-stage bilateral THA
- •Subject willing and able to provide written informed consent
Exclusion Criteria
- •Subject with significant comorbidities identified by Charleston index of ≥ 3
- •Subject with malignancy
- •Subject with history of heart disease, myocardial infarction, pulmonary insufficiency, pulmonary embolus, documented fat emboli syndrome, adult respiratory distress syndrome, documented patent ductus arteriosus or septal defect, chronic renal failure and/or acute hepatic failure or chirhosis
- •Subjects with hematologic disorders such as anemia (Hb \< 10 g/dL) and sickle cell disease, acquired or congenital coagulopathies, acquired or congenital bleeding disorders,
- •Subject who received anticoagulant such as aspirin or Warfarin (Coumadin) or antiplatelet agents such as clopidogrel (Plavix) within 7 days of surgery
- •Subject who received hemostatic agents such as tranexamic acid and aprotinin
- •Subjects utilizing acute normovolumic haemodilution
- •Subject is not permitted to remain without his/her anti-coagulant regimen (eg Plavix) for 48 hours postoperatively
- •Subject is known to be pregnant.
- •Subject has erythropoietin agonist/stimulating agent within 90 days prior to surgery.
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Completed
N/A
Tissue Sparing Surgery in Total Hip ArthroplastyTotal Hip ArthroplastyHip ArthrosisNCT04358250I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio50
Completed
N/A
Randomized Controlled Trial of Total Hip ArthroplastyHip ArthritisTotal Hip Arthroplasty (THA)NCT05093361Kuopio University Hospital120
Completed
N/A
Study Comparing BoneMaster Hydroxyapatite Coating With Plasma-sprayed Hydroxyapatite Coating on Acetabular CupsArthropathy of HipNCT00859976Zimmer Biomet167
Completed
N/A
Study of Total Hip Arthroplasty Using Radlink Surgical Positioning SoftwareTotal Hip ReplacementNCT02536573Anderson Orthopaedic Research Institute200
Completed
N/A
A Prospective Clinical Study On A Total Hip Resurfacing SystemArthritisAvascular NecrosisNCT00604734Zimmer Biomet280